Sign in
Outcomes of Intravitreal Antivascular Endothelial Growth Factor (VEGF) Therapy for Diabetic Macular Edema in Routine Clinical Practice
John D Pitcher, MD
Annual Meeting Talks
2018
Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial
Rishi P. Singh, MD
Surgical Case Conference
Carl C. Awh, MD, FASRS
Carl D. Regillo, MD
Mohamed AlBahiti, MBBS, FRCSC
Mohsin H. Ali, MD
Nishikant J Borse, MS, FMRF, FASRS
Jonathan S Chang, MD
Albert Li, MD, FASRS
Zofia Anna Nawrocka (vel Michalewska), MD, PhD
Manish Nagpal, MD, FRCS (UK) ,FASRS
Berna Ozkan, MD
Uriel Rubin, MD
Jayanth Sridhar, MD
Victor M Villegas, MD
Christina Y Weng, MD, MBA, FASRS
Category: Retinal Detachment